Procathepsin D and cytokines influence the proliferation of lung cancer cells

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 47-51

  Vetvicka, Vaclav ^a   Vetvickova, Jana ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cathepsin; Cytokines; Lung cancer cells; Proliferation

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; PROCATHEPSIN D; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CYTOKINE RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; LUNG CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN SECRETION;

APOPTOSIS; BLOTTING, WESTERN; CATHEPSIN D; CELL PROLIFERATION; CYTOKINES; ENZYME PRECURSORS; FIBROBLASTS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-8; LUNG NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 79851501095     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E and Rey J: Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 291: 157-170, 2000.
2. Vashishta A, Saraswat Ohri S, Proctor M, Fusek M and Vetvicka V: Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. Anticancer Res 26: 4163-4170, 2006. (Pubitemid 46031486)
3. Vetvicka V, Benes P and Fusek M: Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors. Cancer Gene Therapy 9: 854-863, 2002.
4. Chyczewski L, Plonski A, Chyczewska E, Furman M, Ostrowska H and Niklinski J: Activity and tissue localization of cathepsin D in non-small cell lung cancer. Roc Akad Medyc 42: 217-229, 1997.
5. Zhixin W and Xiaoyan Z: Expression and prognostic relation of cathepsin D in non-small lung cancer tissues and lymph nodes. Chin J Tuberc Respir Dis 21: 164-166, 1998.
6. González-Vela MC, Garijo MF, Fernández F, Buelta L and Val-Bernal JF: Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology 34: 35-42, 1999.
7. Benes P, Vetvicka V and Fusek M: Cathepsin D - many functions of one aspartic protease. Crit Rev Oncol Hematol 68: 12-28, 2008.
8. Laurent-Matha V, Maruani-Herrman S, Prebois C, Beaujoin M, Glondu M, Noel A, Alvarez-Gonzales ML, Blacher S, Coopman P, Baghdiguian S, Gilles C, Lancarek J, Freiss G, Vignon F and Liaudet-Coopman E: Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol 168: 489-499, 2005. (Pubitemid 40205070)
9. Jones RJ, Matsui WH and Smith BD: Cancer stem cells: are we missing the target? J Natl Cancer Inst 96: 583-585, 2004.
10. Ronnov-Jessen L, Petersen OW, Koteliansky VE and Bissell MJ: The origin of the myofibroblasts in breast cancer. J Clin Invest 95: 859-873, 1995.
11. Horgan K, Jones DL and Mansel RE: Mitogenicity of human fibroblasts in vivo or human breast cancer cells. Br J Surg 74: 227-229, 1987. (Pubitemid 17044638)
12. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M and Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21: 5951-5955, 2002. (Pubitemid 35007248)
13. Voburka Z, Vetvicka V, Vetvickova J and Fusek M: Cytokines affect procathepsin D-stimulated proliferation of breast cancer cells. Anticancer Res 22: 913-919, 2002. (Pubitemid 34475249)
14. Fusek M, Vetvickova J and Vetvicka V: Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. J Interferon Cytokine Res 27: 191-199, 2007. (Pubitemid 46435486)
15. Vetvicka V and Fusek M: Procathepsin D and human cancer. Curr Topics in Peptide Protein Res 6: 93-99, 2004.
16. Vignon F, Capony F, Chambon M, Freiss G, Garcia M and Rochefort H: Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 188: 1537-1545, 1986. (Pubitemid 16078532)
17. Vetvicka V, Vetvickova J and Fusek M: Effect of procathepsin D and its activation peptide on prostate cancer cells. Cancer Lett 129: 55-59, 1998. (Pubitemid 28375238)
18. Vetvicka V, Vetvickova J and Benes P: Role of enzymatically invasive procathepsin D in lung cancer. Anticancer Res 24: 2739-2744, 2004.
19. Mocellin S, Wang E and Marincola FM: Cytokines and immune response in the tumor microenvironment. J Immunotherapy 24: 392-407, 2001. (Pubitemid 33029909)
20. Takizawa H, Ohtoshi T, Ohta K, Yamashita N, Nirohata S, Hirai K, Jiramatsu K and Ito K: Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res 53: 4175-4181, 1993.
21. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA and Strieter RM: Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409-1415, 1994. (Pubitemid 24129558)
22. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyemura K, Modlin R, Wollman J and Dubinett SM: Human non-small cell lung cancer cells express a Type 2 cytokine pattern. Cancer Res 55: 3847-3853, 1995.
23. Prokopchuk O, Liu Y, Henne-Bruns D and Kornmann M: Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Brit J Cancer 92: 921-928, 2005. (Pubitemid 40462640)
24. Blais Y, Gingras S, Haagensen DE, Labrie F and Simard J: Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol 121: 11-18, 1996. (Pubitemid 26268048)
25. Chi X and Tai HH: Interleukin-4 up-regulates 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) in human lung cancer cells. Exp Cell Res 316: 2251-2259, 2010.
26. Cui X, Yang SC, Sharma S, Heuze-Vourc'h N and Dubinett SM: IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer. Biochem Biophys Res Commun 343: 995-1001, 2006.
27. Keping X: Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12: 375-391, 2001.
28. Brat DJ, Bellail AC and Van Meir EG: The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncology 7: 122-133, 2005. (Pubitemid 40590513)
29. Xu L and Fidler IJ: Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 12: 97-106, 2000.
30. Li A, Varney ML and Singh RK: Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7: 3298-3304, 2001. (Pubitemid 32963857)
31. Boost KA, Sadik CD, Bachman M, Zwissler B, Pfeilschifter J and Muhl H: IFN-gamma impairs release of IL-8 by IL-1beta-stimulates A549 lung carcinoma cells. BMC Cancer 8: 265, 2008.
32. Moore KW, Waal Malefyt R, Coffman RLO and O'Garra A: Interleukin 10 and interleukin 10 receptor. Ann Rev Immunol 19: 683-765, 2001.
33. Vicari AP and Trinchieri G: Interleukin-10 in viral disease and cancer: Exiting the labyrinth? Immunol Rev 202: 223-236, 2001.
34. Moncellin S, Marincola SM and Young HA: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukocyte Biol 78: 1043-1051, 2005.
35. Zeng L, O'Conner C, Zhang J, Kaplan AM and Cohen DA: IL-IO promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine 49: 294-302, 2010.